Cisplatin, gemcitabine, vinorelbine (PGV) vs cisplatin and gemcitabine (PG) vs cisplatin, gemcitabine, paclitaxel (PGT) in advanced NSCLC:: Final analysis a phase III trial

被引：0
|
作者：
Comella, G [1 ]
Frasci, G [1 ]
Panza, N [1 ]
Nicolella, G [1 ]
Manzione, I [1 ]
De Cataldis, G [1 ]
Cioffi, R [1 ]
Micillo, E [1 ]
Lorusso, V [1 ]
Bilancia, D [1 ]
Maiorino, L [1 ]
Piantedosi, FV [1 ]
Mangiameli, A [1 ]
Gravina, A [1 ]
Lamberti, A [1 ]
De Lena, M [1 ]
Comella, P [1 ]
机构：
[1] Tumor Inst Naples, So Italy Cooperat Oncol Grp, Naples, Italy
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A10
引用
收藏
页码：3 / 3
页数：1
相关论文
共 50 条
  • [31] Phase II trial of cisplatin and gemcitabine in patients with advanced gastric cancer
    De Lange, SM
    van Groeningen, CJ
    Kroep, JR
    Van Bochove, A
    Snijders, JF
    Peters, GJ
    Pinedo, HM
    Giaccone, G
    ANNALS OF ONCOLOGY, 2004, 15 (03) : 484 - 488
  • [32] Gemcitabine, Vinorelbine, and Cisplatin in the Treatment of Advanced Nonsmall Cell Lung Cancer
    Hasturk, Serap
    Hatabay, Nilgun
    Ece, Ferah
    Karatasli, Meltem
    Hanta, Ismail
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009, 32 (03): : 280 - 285
  • [33] Randomised, open-label, phase II trial of paclitaxel, gemcitabine and cisplatin versus gemcitabine and cisplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium
    Lorusso, V
    Crucitta, E
    Silvestris, N
    Rosati, G
    Manzione, L
    De Lena, M
    ONCOLOGY REPORTS, 2005, 13 (02) : 283 - 287
  • [34] Pharmacology of the paclitaxel-cisplatin, gemcitabine-cisplatin, and paclitaxel-gemcitabine combinations in patients with advanced non-small cell lung cancer
    Kroep, J. R.
    Smit, E. F.
    Giaccone, G.
    Van der Born, K.
    Beijnen, J. H.
    Van Groeningen, C. J.
    Van der Vijgh, W. J. F.
    Postmus, P. E.
    Pinedo, H. M.
    Peters, G. J.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 58 (04) : 509 - 516
  • [35] A comparison of the costs of gemcitabine/cisplatin and gemcitabine/carboplatin combination regimens in the treatment of advanced NSCLC in the UK and France
    Tilden, DP
    Aristides, M
    Stynes, G
    Kielhorn, A
    Bhalla, S
    VALUE IN HEALTH, 2002, 5 (06) : 542 - 542
  • [36] The Combination of Gemcitabine, Cisplatin, and Paclitaxel as Salvage Chemotherapy for Advanced Urothelial Carcinoma
    Hirata, Takeshi
    Hanamoto, Masanori
    Ogura, Kazuma
    Hayashi, Nobuki
    Takamura, Kosuke
    Edamura, Kohei
    Ebara, Shin
    Saika, Takashi
    ACTA MEDICA OKAYAMA, 2018, 72 (02) : 175 - 179
  • [37] Gemcitabine-cisplatin-vinorelbine phase II trial in stage III non small cell lung cancer
    Cueva, JF
    Grande, C
    Firvida, J
    Amenedo, M
    Lázaro, M
    Romero, C
    Quintero, G
    Huidobro, G
    García, J
    Barón, FJ
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S259 - S259
  • [38] Gemcitabine and cisplatin in advanced non small cell lung cancer (NSCLC)
    Garcia-Gomez, R
    Lopez-Criado, P
    Guevara, S
    Lahoz, C
    Chaib, C
    Gonzalez, C
    Santiago, J
    De Alvaro, J
    Carrion, R
    Perez-Manga, G
    ANNALS OF ONCOLOGY, 1998, 9 : 93 - 94
  • [39] Economic analysis of a randomized phase III trial of gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer (Italian GEMVIN3/NCIC CTG BR14 trial)
    Reaume, M. Neil
    Leighl, Natasha B.
    Mittmann, Nicole
    Coyle, Doug
    Hirsh, Vera
    Seymour, Lesley
    Tu, Dongsheng
    Shepherd, Frances A.
    Graham, Barbara
    Gridelli, Cesare
    Perrone, Francesco
    Di Maio, Massimo
    Bradbury, Penelope A.
    Evans, William K.
    LUNG CANCER, 2013, 82 (01) : 115 - 120
  • [40] Gemcitabine/cisplatin (G/P) vs gemcitabine/vinorelbine (G/V) in the treatment of non-small cell lung cancer (NSCLC). Stage IIIB and IV.
    Galvez, C
    Galmarini, F
    ANNALS OF ONCOLOGY, 2000, 11 : 115 - 116
12345